Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Living, you said: "how is declaring WG a shareholder finding evidence?"

Living, you need to develop an objective foundation in which you actually research and present your own DD instead of asking others to present theirs all the time.

This will come with time and market maturity. You can start with researching the RXPC patent applications for New Zealand and Australia. If your information proves to be reliable, we can go from there.